Abstract | OBJECTIVE: Lung transplant recipients have an increased de novo cancer risk due to long-term immunosuppression and several oncogenic viral infections. In Japan, to date, there have been no national surveys of the incidence of de novo malignancy after lung transplantation. METHODS: This national survey was conducted by the Japanese Society for Transplantation. The questionnaire was distributed to lung transplant institutions, asking about several clinical factors related to de novo malignancy patients transplanted from 2001 to 2010. RESULTS: CONCLUSIONS:
|
Authors | Takuro Miyazaki, Takahiro Oto, Meinoshin Okumura, Hiroshi Date, Takeshi Shiraishi, Yoshinori Okada, Masayuki Chida, Takashi Kondo, Takeshi Nagayasu |
Journal | General thoracic and cardiovascular surgery
(Gen Thorac Cardiovasc Surg)
Vol. 64
Issue 9
Pg. 543-8
(Sep 2016)
ISSN: 1863-6713 [Electronic] Japan |
PMID | 27270709
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Female
- Humans
- Immunosuppression Therapy
(adverse effects)
- Immunosuppressive Agents
(adverse effects)
- Incidence
- Japan
(epidemiology)
- Lung Transplantation
(adverse effects)
- Middle Aged
- Neoplasms
(epidemiology)
- Postoperative Complications
(epidemiology)
- Retrospective Studies
- Treatment Outcome
- Young Adult
|